December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Keros Therapeutics, Inc. - common stock (NQ:KROS)

15.04 -0.14 (-0.92%)
Streaming Delayed Price Updated: 9:46 AM EDT, Oct 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,002
Open 15.15
Bid (Size) 15.03 (2)
Ask (Size) 15.15 (2)
Prev. Close 15.18
Today's Range 15.04 - 15.15
52wk Range 9.120 - 72.37
Shares Outstanding 23,337,862
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Keros Therapeutics' Quiet Near-Term Outlook Overshadows Pipeline Potential: Analyst
BofA's Zemansky downgraded Keros to Neutral, citing limited near-term upside, cautious sentiment, and unresolved investor concerns. 
Via Benzinga
Keros Therapeutics Stops PAH Drug Development, Shrinks Workforce By 45%
Keros ends PAH development of cibotercept after Phase 2 safety issues, including pericardial effusions, and plans to cut 45% of workforce amid review. 
Via Benzinga

Performance

YTD
-5.5%
-5.5%
1 Month
-5.7%
-5.7%
3 Month
+3.9%
+3.9%
6 Month
+4.1%
+4.1%
1 Year
-75.2%
-75.2%

More News

Read More
Deal Dispatch: Harley-Davidson To Wipe Out? Plus, Prada's Versace Purchase Garners A Fashionable Price
Via Benzinga
Keros Therapeutics Goes Up For Sale On Heels Of Stockholder Rights Plan
Via Benzinga
Analyst Expectations For Keros Therapeutics's Future
Via Benzinga
Deep Dive Into Keros Therapeutics Stock: Analyst Perspectives (11 Ratings)
Via Benzinga
Where Keros Therapeutics Stands With Analysts
Via Benzinga
These stocks are gapping in today's session
Via Chartmill
Keros Therapeutics Adopts Defense Strategy Against Potential Hostile Takeover, Explores Sale: Retail’s Overjoyed
Via Stocktwits
Crude Oil Falls Over 4%; Keros Therapeutics Shares Jump
Via Benzinga
PriceSmart Posts Better-Than-Expected Earnings, Joins Enact Holdings, DexCom And Other Big Stocks Moving Higher On Thursday
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Forecasting The Future: 7 Analyst Projections For Keros Therapeutics
Via Benzinga
KEROS ALERT: Bragar Eagel & Squire, P.C. is Investigating Keros Therapeutics, Inc. on Behalf of Keros Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Keros Therapeutics, Inc. (KROS)
From Kirby McInerney LLP
Via Business Wire
Crude Oil Rises Sharply; JPMorgan Chase Earnings Top Views
Via Benzinga
Nasdaq Surges Over 2%; Goldman Sachs Posts Upbeat Q4 Results
Via Benzinga
Keros Therapeutics Stock Heads For Record Low After Dosing Halt In Pulmonary Disease Trial, Retail Buzz Spikes
Via Stocktwits
Keros Therapeutics, Inc. Investigation Ongoing: Contact Levi & Korsinsky to Discuss Your Rights - KROS
Via ACCESSWIRE
Shareholders that lost money on Keros Therapeutics, Inc.(KROS) should contact Levi & Korsinsky about Securities Fraud Investigation - KROS
Via ACCESSWIRE
Levi & Korsinsky Announces an Investigation on Behalf of Keros Therapeutics, Inc. (KROS) Shareholders Who May Have Been Affected by Fraud
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Dow Tumbles 200 Points; Liquidity Services Shares Spike Higher
Via Benzinga
Topics Stocks
Gold Falls Sharply; Adobe Shares Dip After Weak Revenue Outlook
Via Benzinga
Nasdaq Down 50 Points; US Initial Jobless Claims Rise
Via Benzinga

Frequently Asked Questions

Is Keros Therapeutics, Inc. - common stock publicly traded?
Yes, Keros Therapeutics, Inc. - common stock is publicly traded.
What exchange does Keros Therapeutics, Inc. - common stock trade on?
Keros Therapeutics, Inc. - common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Keros Therapeutics, Inc. - common stock?
The ticker symbol for Keros Therapeutics, Inc. - common stock is KROS on the Nasdaq Stock Market
What is the current price of Keros Therapeutics, Inc. - common stock?
The current price of Keros Therapeutics, Inc. - common stock is 15.04
When was Keros Therapeutics, Inc. - common stock last traded?
The last trade of Keros Therapeutics, Inc. - common stock was at 10/29/25 09:46 AM ET
What is the market capitalization of Keros Therapeutics, Inc. - common stock?
The market capitalization of Keros Therapeutics, Inc. - common stock is 351.00M
How many shares of Keros Therapeutics, Inc. - common stock are outstanding?
Keros Therapeutics, Inc. - common stock has 351M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.